|
Examining The Family Tree: Discovering The Risks With
Genetics And Cancer
 |
We are just at the very beginning of our knowledge base. Genes are going
to be identified that predispose or contribute to lung, prostate, skin and other
cancers."
— Bob Young, Ph.D. |
Their work began with just a handful of families. Some six years later the number
of patients referred to them annually exceeds a couple hundred. Yet Dr. Robert
Young, director of Cancer and Research Genetics, based in the Department of Obstetrics
and Gynecology, describes the inception of the Cancer Genetics Program not as
a carefully crafted plan, but rather “something that just happened.”
The time was the mid 1990's. A 20-year veteran at the School of Medicine,
Dr. Young already had the establishment of USC’s comprehensive prenatal/pediatrics
genetic program to his credit. Then he shifted gears in his research and began
looking at ovarian cancer. Around this same time on the national scene, cancer
researchers announced the identification of BRCA1 and BRCA2, two inherited gene
mutations that put women at increased risk of developing breast and ovarian cancer.
Locally, Dr. Young began attending weekly breast cancer conferences at which
cases were presented and treatment options discussed. He recalls his initial
presence among the oncologists, radiologists, pathologists, and surgeons. “In
the beginning they didn’t know who I was and I’d just keep my mouth
shut. Then slowly I started asking, ‘Is there any family history of cancer
in this situation?’”
Over time the physicians began asking for Dr. Young’s input at the breast
cancer conferences. Another development occurred as well. He recalls, “Once
oncologists in town realized that I was a geneticist who knew something about
cancer, they started having their patients who were worried about their family
history call me.” It wasn’t long before the demand for genetic counseling
services was more than Dr. Young could handle. That’s when Karen Brooks,
a genetic counselor in the Department of OB/GYN with a prenatal and pediatric
background, shifted her focus to become the School of Medicine’s cancer
genetics counselor.
Cancer Genetic Counseling
Karen Brooks estimates that half of her patients already have a cancer diagnosis.
They’re looking to learn if their heredity increases the risk of other
cancers in themselves or the development of cancer in close relatives. The other
half are unaffected by cancer, but have a number of family members who are. They
also want to ascertain the potential genetic impact. The first step Brooks takes
is to create a pedigree or a family medical tree by compiling health histories
of at least three generations of relatives. The task of piecing together the
incidence of cancer in families can be a challenging one. “Sometimes people
can get the information and sometimes they can’t,” said Brooks, who
explains that written diagnostic records or pathology reports are preferred for
the most accurate accounting. She also finds that, “some patients have
done their detective work and come in with their mother’s medical records
from 1965.”
The process continues with a cancer risk assessment, in which Brooks looks
for a pattern of potentially related cancers, such as breast cancer and ovarian
cancer or colon cancer and uterine cancer, which tend to run together in families.
If such a pattern is established, patients may choose to undergo genetic testing. “I
explore with patients their reasons for wanting the genetic testing done. Many
people tell me that they want to know for their relatives’
sake – their children, siblings etc.,” Brooks said.
The information revealed from the blood test may influence any number of decisions
on how patients decide to address their health risks.
“For example, someone with a colon cancer mutation may want
to have more frequent colonoscopies and start them at an earlier age,” she
said.
Genetic Mutation
When the presence of a BRCA gene mutation is established, it dramatically
increases a woman’s likelihood of developing breast cancer.
“We know that if you live to be 50, you have up to a 50 percent
chance of getting the disease; if you live to be 70, you have up to a 70 percent
chance. You could have a mammogram in January and develop the cancer in February;
we just don’t know when you will get it,” explained Dr. Young. Armed
with this information, some women start on a chemoprevention medication such
as tamoxifen. Others elect to have a mastectomy as a preventive measure, known
as a risk reduction mastectomy. “I seem to have more and more patients
coming in who say, ‘Yes, I would consider having both my breasts removed
if I have a mutated gene,’”
Brooks said.
Uncovering a significant risk of cancer is not without significant emotional
impact, and part of Brooks’ job is helping patients maneuver through that
rocky terrain. “I encourage patients to bring a support person when they
come in for test results, especially if it’s going to be an emotionally
charged situation,”
she said.
While the majority of Brooks’ patients (a total of 240 in 2003) are
referred because of a family history of breast cancer, a small but growing number
come to her because of colon cancer and other types of cancers. She and Dr. Young
now attend a monthly gastrointestinal tumor board, and envision that referrals
from colorectal surgeons and gastroenterologists will be on a steady increase. “We
figure that there are about 160 patients a year with a colon cancer history in
the Midlands that we’re not seeing right now,”
said Dr. Young. He added, “We have come a tremendous way
in educating physicians on the role of family history,” he said, which
reflects in the growth of the Cancer Genetics Program.
Providing education on the role of genetics and cancer has been an important
component of Dr. Young and Brooks’ work. A staple of presentations that
Brooks makes to medical personnel and community groups is the 3-2-1 Principle. “If
three individuals in a family are affected with the same or related malignancy,
if two are first degree relatives (such as siblings or a parent and a child),
and if one is diagnosed prior to age 50, then that family should minimally seek
the advice of a genetic professional,” she explains to groups.
As cancer research continues, the Cancer Genetics Program is likely to continue
to expand. “We are just at the very beginning of our knowledge base. Genes
are going to be identified that predispose or contribute to lung, prostate, skin
and other cancers. It’s inevitable,” Dr. Young said. For families
with cancer in their family tree that could mean more access to information that
could help safeguard the health of generations to come. “Our patients seem
to be very proactive; they want to do something to help themselves and their
families. It’s very inspiring,” Brooks said.
Reprinted from Connections newsletter, March 2004
Connections is produced twice a year by University Specialty Clinics. Connections articles
are copyrighted and may be download and/or reprinted for personal use only. Prior
written consent is required in order to reprint or electronically reproduce any
articles, graphics, and photographs appearing on the website. For more information,
contact Diane J. Epperly, Connections editor, at wordchef@atlanticbb.net .
|